Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TCEB2 encodes the protein elongin B, which is a subunit of the transcription factor B (SIII) complex. Additionally we are shipping Transcription Elongation Factor B (SIII), Polypeptide 2 (18kDa, Elongin B) Proteins (15) and Transcription Elongation Factor B (SIII), Polypeptide 2 (18kDa, Elongin B) Kits (3) and many more products for this protein.
Showing 10 out of 99 products:
Human Monoclonal TCEB2 Primary Antibody for IF, WB - ABIN394425
Sowa, Bennett, Gygi, Harper: Defining the human deubiquitinating enzyme interaction landscape. in Cell 2009
Show all 5 references for ABIN394425
Human Polyclonal TCEB2 Primary Antibody for EIA, WB - ABIN955125
Van Herreweghe, Egloff, Goiffon, Jády, Froment, Monsarrat, Kiss: Dynamic remodelling of human 7SK snRNP controls the nuclear level of active P-TEFb. in The EMBO journal 2007
Show all 3 references for ABIN955125
Human Monoclonal TCEB2 Primary Antibody for BCA - ABIN2661163
DeRenzo, Reese, Seydoux: Exclusion of germ plasm proteins from somatic lineages by cullin-dependent degradation. in Nature 2003
Show all 3 references for ABIN2661163
Human Polyclonal TCEB2 Primary Antibody for WB - ABIN658243
Bullock, Debreczeni, Edwards, Sundström, Knapp: Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. in Proceedings of the National Academy of Sciences of the United States of America 2006
Show all 2 references for ABIN658243
Crystal structure shows interaction between SOCS2 (show SOCS2 Antibodies)-elongin BC and Cullin-5 (show CUL5 Antibodies).
both P-TEFb (show CCNT1 Antibodies) activity and H1 phosphorylation are necessary for the full differentiation of C2C12 myoblasts into myotubes.
Elongin B/C recruitment regulates substrate binding by CIS (show CISH Antibodies)
SOCS (show CISH Antibodies) box acts as an independent binding domain capable of recruiting elonginBC and cullin5 to promote E3 ligase formation.
Study shows that TCEB2 is involved in the development of acquired resistance to bevacizumab in ovarian cancer cells via the mechanisms of suppression of VEGF-A (show VEGFA Antibodies) expression by promoting HIF-1alpha (show HIF1A Antibodies) degradation and induction of interleukin-8 (IL-8 (show IL8 Antibodies)) expression.
crystals of SOCS2 (show SOCS2 Antibodies) in complex with its adaptor proteins, Elongin C (show TCEB1 Antibodies) and Elongin B, underwent a change in crystallographic parameters when treated with dimethyl sulfoxide during soaking experiments.
The crystal structure of VHL (show VHL Antibodies) bound to a Cul2 (show CUL2 Antibodies) N-terminal domain, Elongin B, and Elongin C (show TCEB1 Antibodies).
Vif (show BTG1 Antibodies) interaction with EloB-EloC (show TCEB1 Antibodies) may contribute to recruitment of CBF-beta (show CBFB Antibodies) to Vif (show BTG1 Antibodies), demonstrating that the EloB C-teminus may play a role in improving Vif (show BTG1 Antibodies) function and that the over-expression of EloB results in Vif (show BTG1 Antibodies) stabilization.
ASB9 (show ASB9 Antibodies) is unstable alone but forms a stable ternary complex with EloBC that binds with high affinity to the Cullin 5 (show CUL5 Antibodies) N-terminal domain.
Elongin B also enhances gene expression from the double-stranded DNA genome of human cytomegalovirus.
Recombinant full-length Vif (show BTG1 Antibodies) interacted with the Elongin BC complex in vitro with a K(d) of 1.9 muM and resulted in observable changes in deuterium uptake in both Elongin C (show TCEB1 Antibodies) and B.
findings report that HIV-1 Vif (show BTG1 Antibodies) interacts with cellular proteins Cul5 (show CUL5 Antibodies), elongins B and C, and Rbx1 to form an Skp1 (show SKP1 Antibodies)-cullin-F-box (SCF (show KITLG Antibodies))-like complex
show that ASB2, by interacting with the Elongin BC complex, can assemble with Cullin5.Rbx1 to form an E3 ubiquitin ligase complex that stimulates polyubiquitination by the E2 ubiquitin-conjugating enzyme Ubc5
the E3 ubiquitin ligase (show MUL1 Antibodies) activity of the Vif (show BTG1 Antibodies)-BC-Cul5 (show CUL5 Antibodies) complex is essential for Vif (show BTG1 Antibodies) function against APOBEC3G (show APOBEC3G Antibodies)
This gene encodes the protein elongin B, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. Pseudogenes have been identified on chromosomes 11 and 13.
18 kDa, elongin B
, RNA polymerase II transcription factor SIII subunit B
, SIII p18
, elongin 18 kDa subunit
, elongin B
, transcription elongation factor B (SIII), polypeptide 2 (18 kDa, elongin B)
, transcription elongation factor B polypeptide 2
, transcription elongation factor B (SIII) polypeptide 2 (18kD, elongin B)
, transcription elongation factor B, polypeptide 2
, RNA polymerase II transcription factor SIII p18 subunit
, elongin, 18-kD subunit